AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2025
Dec 3, 2025
31708_dirs_2025-12-03_306c42e4-5449-48cf-9b15-ff8838a6c3e3.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2025-12-02
Reporting Person: Pellegrino Joseph P JR (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-12-02 | Common Stock | M | 15 | — | Acquired | 9581 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-12-02 | Dividend Equivalent Rights | $ | M | 15 | Disposed | Common Stock (15) | Direct |
Footnotes
F1: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.
F2: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.
F3: Fractional shares released (if any) on each vesting date were settled in cash, resulting in a final balance of zero.
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Regulatory Filings
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3